Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1–7) through a p38 MAPK-dependent mechanism
The DOI matches its Crossref record; 94 of the 97 references it cites were found in a registry or an index.
Abstract
Skeletal muscle atrophy induced during sepsis syndrome produced by endotoxin in the form of LPS (lipopolysaccharide), is a pathological condition characterized by the loss of strength and muscle mass, an increase in MHC (myosin heavy chain) degradation, and an increase in the expression of atrogin-1 and MuRF-1 (muscle-specific RING-finger protein 1), two ubiquitin E3 ligases belonging to the ubiquitin–proteasome system. Ang-(1–7) [Angiotensin-(1–7)], through its Mas receptor, has beneficial effects in skeletal muscle. We evaluated in vivo the role of Ang-(1–7) and Mas receptor on the muscle wasting induced by LPS injection into C57BL/10J mice. In vitro studies were performed in murine C2C12 myotubes and isolated myofibres from EDL (extensor digitorum longus) muscle. In addition, the participation of p38 MAPK (mitogen-activated protein kinase) in the Ang-(1–7) effect on the LPS-induced muscle atrophy was evaluated. Our results show that Ang-(1–7) prevents the decrease in the diameter of myofibres and myotubes, the decrease in muscle strength, the diminution in MHC levels and the induction of atrogin-1 and MuRF-1 expression, all of which are induced by LPS. These effects were reversed by using A779, a Mas antagonist. Ang-(1–7) exerts these anti-atrophic effects at least in part by inhibiting the LPS-dependent activation of p38 MAPK both in vitro and in vivo. We have demonstrated for the first time that Ang-(1–7) counteracts the skeletal muscle atrophy induced by endotoxin through a mechanism dependent on the Mas receptor that involves a decrease in p38 MAPK phosphorylation. The present study indicates that Ang-(1–7) is a novel molecule with a potential therapeutic use to improve muscle wasting during endotoxin-induced sepsis syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding skeletal muscle, there is broad evidence about the antiatrophic and antisarcopenic role of Ang-(1-7) [141–144].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [142]
In the citing paper
“an age-related decrease in gut Bifidobacterium content may underlie increases in circulating endotoxin that are shown to induce skeletal muscle atrophy [71].”
From Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis (2018) · cites this paper as [71]
Citations
Cites
1 retracted
Li, Y., Cao, Y., Zeng, Z., Liang, M., Xue, Y., Xi, C., Zhou, M., & Jiang, W. (2015) · Scientific Reports · doi:10.1038/srep08209 · Cited by 104
RetractedSandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
Raetz, C. R. H. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001021 · Cited by 1,230
Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?
Son, Y., Cheong, Y.-K., Kim, N.-H., Chung, H.-T., Kang, D. G., & Pae, H.-O. (2011) · Journal of Signal Transduction · doi:10.1155/2011/792639 · Cited by 1,219
Skeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 669
Research works printed but not linked: 1
- Moldawer, 1997, Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options, Cancer, 79, 1828, 10.1002/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.0.CO;2-Z · doi:10.1002/(sici)1097-0142(19970501)79:9<1828::aid-cncr28>3.0.co;2-z
Cited by
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Grosicki, G. J., Fielding, R. A., & Lustgarten, M. S. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0345-5 · Cited by 388
“Thus, an age-related decrease in gut Bifidobacterium content may underlie increases in circulating endotoxin that are shown to induce skeletal muscle atrophy [71].”
BackgroundNi, Y., Yang, X., Zheng, L., Wang, Z., Wu, L., Jiang, J., Yang, T., Ma, L., & Fu, Z. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900603 · Cited by 255
Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia
Picca, A., Fanelli, F., Calvani, R., Mulè, G., Pesce, V., Sisto, A., Pantanelli, C., Bernabei, R., Landi, F., & Marzetti, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/7026198 · Cited by 181
“Thus, an age-related decrease in gut Bifidobacterium content may underlie increases in circulating endotoxin that are shown to induce muscle atrophy [100].”
BackgroundHwang, J.-S., Kim, K.-H., Park, J., Kim, S.-M., Cho, H., Lee, Y., & Han, I.-O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004638 · Cited by 167
“Activation of MAPK and NF- B signaling increases the production of proinflammatory cytokines (31) and inhibition of MAPK significantly reduces mortality associated with sepsis in rats with endotoxic shock (31).”
BackgroundFielding, R. A., Reeves, A. R., Jasuja, R., Liu, C., Barrett, B. B., & Lustgarten, M. S. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110722 · Cited by 163
Abrigo, J., Rivera, J. C., Aravena, J., Cabrera, D., Simon, F., Ezquer, F., Ezquer, M., & Cabello-Verrugio, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9047821 · Cited by 109
“The mRNA levels were expressed relative to the mean expression in the vehicle-treated mice [23, 28].”
Self-citationKarnik, S. S., Singh, K. D., Tirupula, K., & Unal, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13742 · Cited by 105
“These effects were reversed by the MAS1 receptor antagonist A-779 (Cabello-Verrugio et al., 2015; Morales et al., 2015).”
BackgroundImpact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Ábrigo, J., González, F., Aguirre, F. S., Tacchi, F., González, A., Meza, M. P., Simón, F., Cabrera, D., Arrese, M. A., Karpen, S. J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29839 · Cited by 93
“Other authors and we have shown that these muscle‐specific E3 ligases are typical markers of muscle atrophy and indicators of UPS overactivation (Abrigo et al., 2016; Attaix et al., 2005; Campos et al., 2018; Morales et al., 2015).”
BackgroundSelf-citationThe critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
Self-citationAn Integrated Approach to Skeletal Muscle Health in Aging
Agostini, D., Gervasi, M., Ferrini, F., Bartolacci, A., Stranieri, A., Piccoli, G., Barbieri, E., Sestili, P., Patti, A., Stocchi, V., et al. (2023) · Nutrients · doi:10.3390/nu15081802 · Cited by 88
Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review)
Yang, W., Huang, J., Wu, H., Wang, Y., Du, Z., Ling, Y., Wang, W., Wu, Q., & Gao, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11608 · Cited by 70
Ábrigo, J., Rivera, J. C. A., Simón, F., Cabrera, D., & Cabello‐Verrugio, C. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.010 · Cited by 69
Self-citationThe Renin-Angiotensin System and Skeletal Muscle
Powers, S. K., Morton, A. B., Hyatt, H. W., & Hinkley, J. M. (2018) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000158 · Cited by 70
Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice
Qiu, Y., Yu, J., Ji, X., Yu, H., Xue, M., Zhang, F., Li, Y., & Bao, Z. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111630 · Cited by 62
Cabrera, D., Ruiz, A., Cabello‐Verrugio, C., Brandan, E., Estrada, L. D., Pizarro, M., Solís, N., Torres, J., Francisco Barrera, M., & Arrese, M. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4285-0 · Cited by 56
Self-citationTakeshita, H., Yamamoto, K. I., Nozato, S., Takeda, M., Fukada, S., Inagaki, T., Tsuchimochi, H., Shirai, M., Nozato, Y., Fujimoto, T., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12334 · Cited by 49
“Underlying mechanisms proposed in these studies regarding the effects of A1-7 include phosphorylation of AKT, prevention of the increase in atrogin-1 and MuRF-1,(9,11) reduction in phosphorylation of p38 MAPK, and inhibition of transforming growth factor-β signalling.(10,12,13) We did not find any influence of A1-7 on…”
Angiotensin-(1–7) attenuates organ injury and mortality in rats with polymicrobial sepsis
Tsai, H.-J., Liao, M., Shih, C.-C., Ka, S., Tsao, C., & Wu, C.-C. (2018) · Critical Care · doi:10.1186/s13054-018-2210-y · Cited by 47
Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer
Murphy, K. T., Hossain, M. I., Swiderski, K., Chee, A., Naim, T., Trieu, J., Haynes, V. R., Read, S. J., Stapleton, D., Judge, S. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1207 · Cited by 51
“Since activation of the ACE2/Ang-(1-7)/MasR axis protects against muscle wasting in various conditions including disuse (16) and endotoxin-induced sepsis (17), we investigated the downstream mediators of this response in a non-targeted and non-biased manner to direct the focus of our subsequent in vivo analyses.”
BackgroundInfluentialConforto, R., Rizzo, V., Russo, R., Mazza, E., Maurotti, S., Pujia, C., Succurro, E., Arturi, F., Ferro, Y., Sciacqua, A., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156052 · Cited by 48
Small molecule adiponectin receptor agonist GTDF protects against skeletal muscle atrophy
Singh, A. K., Shree, S., Chattopadhyay, S., Kumar, S., Gurjar, A., Kushwaha, S., Kumar, H., Trivedi, A. K., Chattopadhyay, N., Maurya, R., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.013 · Cited by 42
“LPS and TNF-α treatment induce skeletal muscle atrophy and these factors are 331 primary mediators of atrophy in sepsis (Morales et al., 2015,Reid and Li, 2001).”
BackgroundAngiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal Muscle Atrophy
Aravena, J., Ábrigo, J., González, F., Aguirre, F. S., González, A., Simón, F., & Cabello‐Verrugio, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031167 · Cited by 44
Self-citationNozato, S., Yamamoto, K., Takeshita, H., Nozato, Y., Imaizumi, Y., Fujimoto, T., Yokoyama, S., Nagasawa, M., Takeda, M., Hongyo, K., et al. (2019) · Clinical Science · doi:10.1042/cs20190573 · Cited by 37
Miao, C., Lv, Y., Zhang, W., Chai, X., Feng, L., Fang, Y., Liu, X., & Zhang, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00915 · Cited by 37
“Endotoxininduced skeletal muscle wasting was reported to be through a p38 MAPK-dependent mechanism (Morales et al., 2015).”
BackgroundTherapeutic approaches targeting renin-angiotensin system in sepsis and its complications
Ning, L., Rong, J., Zhang, Z., & Xu, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105409 · Cited by 36
Ábrigo, J., Simon, F., Cabrera, D., & Cabello-Verrugio, C. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452522 · Cited by 35
Self-citationSkeletal muscle wasting: new role of nonclassical renin–angiotensin system
Cabello‐Verrugio, C., Rivera, J. C. A., & García, D. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000361 · Cited by 37
Self-citationTsai, H.-J., Shih, C., Chang, K.-Y., Liao, M., Liaw, W., Wu, C.-C., & Tsao, C. (2021) · Scientific Reports · doi:10.1038/s41598-020-79902-x · Cited by 34
González, A., Orozco-Aguilar, J., Achiardi, O. A., Simón, F., & Cabello‐Verrugio, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217904 · Cited by 41
Self-citationMárquez‐Miranda, V., Ábrigo, J., Rivera, J. C. A., Araya‐Durán, I., Aravena, J., Simón, F., Pacheco, N., González-Nilo, F. D., & Cabello‐Verrugio, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125521 · Cited by 33
“7 18 Therefore, finding the mechanisms that potentiate the anti-atrophic actions of Ang-(1–7) is relevant in a therapeutic context.”
Self-citationRivera, J. C. A., Ábrigo, J., Tacchi, F., Simón, F., Brandan, E., Santos, R. A. S., Bäder, M., Chiong, M., & Cabello‐Verrugio, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249344 · Cited by 32
“The treatments were performed by 18 h, except for muscle strength (14 days) or contractile measurements (24 h) such as we and others have previously reported [9,54].”
BackgroundMethodResultInfluentialSelf-citationSenatore, F. F., Balakumar, P., & Jagadeesh, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105916 · Cited by 35
Angiotensin‐(1‐7) and Obesity: Role in Cardiorespiratory Fitness and COVID‐19 Implications
Motta‐Santos, D., Santos, R. A. S., & Santos, S. H. S. (2020) · Obesity · doi:10.1002/oby.22949 · Cited by 34
“Therefore, it is important to highlight that the possible protective effects of physical training may involve the mainstream actions of the ACE2/Ang- (1-7)/Mas axis.”
BackgroundInfluentialPérez, V., Bermedo‐García, F., Zelada, D., Court, F. A., Pérez, M. Á., Fuenzalida, M., Ábrigo, J., Cabello‐Verrugio, C., Moya‐Alvarado, G., Tapia, J. C., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0802-7 · Cited by 28
“Specific net force was determined from the relationship between isometric net force (mN/mm2) using total muscle fiber cross-sectional area (mm(2)) to calculate it, as described [60].”
MethodSelf-citationHong, L., Wang, Q., Chen, M., Shi, J., Guo, Y., Liu, S., Pan, R., Yuan, X., & Jiang, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111365 · Cited by 27
Liu, Y., Wang, X., Leng, W., Pi, D., Tu, Z., Zhu, H., Shi, H., Li, S., Hou, Y., & Hu, C. A. (2016) · Innate Immunity · doi:10.1177/1753425916673443 · Cited by 20
“LPS challenge has been shown to decrease the diameter of myofibers and myotubes, and increase myosin heavy chain degradation and induce the loss of muscle strength and mass in mice.(30) Our previous research showed that dietary addition of 0.”
BackgroundTakeshita, H., Yamamoto, K. I., Mogi, M., Nozato, S., Horiuchi, M., & Rakugi, H. (2019) · Hypertension Research · doi:10.1038/s41440-019-0375-7 · Cited by 17
Zhang, W., Zhang, H., Zhang, Q., Jiao, F., Zhang, H., Wang, L.-W., & Gong, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5324 · Cited by 21
Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians
Afsar, B., Afsar, R. E., Caliskan, Y., Lentine, K. L., & Edwards, J. C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05043-8 · Cited by 15
“Indeed, as suggested above, Ang (1–7)/Mas axis has favorable actions in sarcopenia [2, 23, 24, 37].”
Have, G. A. M. T., Deutz, R. C. I., ENGELEN, M. P. K. J., Wolfe, R. R., & Deutz, N. E. P. (2017) · Laboratory Animals · doi:10.1177/0023677217718003 · Cited by 16
Zambelli, V., Sigurtà, A., Rizzi, L., Zucca, L., Delvecchio, P., Bresciani, E., Torsello, A., & Bellani, G. (2019) · Intensive Care Medicine Experimental · doi:10.1186/s40635-018-0218-x · Cited by 16
Xiao, Q., Chen, Y.-H., Pratama, S. A., Chen, Y.-L., Shirakawa, H., Peng, H.-C., & Yang, S.-C. (2021) · Nutrients · doi:10.3390/nu13082788 · Cited by 13
“It was previously demonstrated that endotoxin caused skeletal muscle atrophy in sepsis syndrome patients and ALD patients [5,6,64].”
BackgroundTakeshita, H., Yamamoto, K. I., Mogi, M., Nozato, S., & Rakugi, H. (2023) · Hypertension Research · doi:10.1038/s41440-023-01189-y · Cited by 12
“various mouse models of induced skeletal muscle damage, with AII [33–35], endotoxin injection [36], disuse atrophy [37], and gene induction of muscular dystrophy [32].”
BackgroundSalles, J., Gueugneau, M., Patrac, V., Malnero-Fernandez, C., Guillet, C., Bacquer, O. L., Giraudet, C., Sanchez, P., Collin, M., Hermet, J., et al. (2023) · Nutrients · doi:10.3390/nu15173766 · Cited by 14
“Intestinal Bifidobacterium content decreases with age [44], and an age-related decrease in gut Bifidobacterium content may be the mechanism underpinning the increase in circulating endotoxin that induces muscle atrophy [45].”
InfluentialThe Role of the Gut Microbiome in Orthopedic Surgery—a Narrative Review
Hiltzik, D. M., Goodwin, A. M., Kurapaty, S. S., Inglis, J. E., Pagadala, M. S., Edelstein, A. I., & Hsu, W. K. (2023) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-023-09878-4 · Cited by 11
“…link between gut health and muscle mass. Bacterial endotoxins (e.g., LPS) and various proinflammatory cytokines (e.g., TNF-a, IL-1B, IL-6, TWEAK) have been shown to induce muscle atrophy, and it is well-known that dysbiosis can lead to increased systemic circulation of these factors [33, 34].”
Yamamoto, K. Z., Ohsumi, S., Nagashima, T., Akiyama, H., Honda, H., & Shimizu, K. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28125 · Cited by 11
“…the proliferation or differentiation of myoblasts and/or myotubes in vitro) were selected from the literature (Bruno et al., 2018; Lee et al., 2017; Morales et al., 2015; Muthuramalingam et al., 2019; Rende et al., 2001; Vinel et al., 2018) and used for the screening of peptides for preventing…”
MethodWang, Z., Sa, G., Wei, Z., Dai, X., Wan, Q., & Yang, X. (2020) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2020.01.017 · Cited by 7
Takeshita, H., Yamamoto, K. I., Mogi, M., Wang, Y., Nozato, Y., Fujimoto, T., Yokoyama, S., Hongyo, K., Nakagami, F., Akasaka, H., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.021030 · Cited by 6
“14-18 However, this protective effect is not observed in aging-associated muscle weakness.”
Angiotensin-(1-7) improves skeletal muscle regeneration
Valero‐Breton, M., Tacchi, F., Ábrigo, J., Simón, F., Cabrera, D., & Cabello‐Verrugio, C. (2023) · European Journal of Translational Myology · doi:10.4081/ejtm.2023.12037 · Cited by 15
“36 In our model of muscle regeneration, once the injury induction, we observed a gradual decrease in Mas receptor levels from 2 to 13 days after injury.”
Self-citationSigurtà, A., Zambelli, V., & Bellani, G. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.07.013 · Cited by 7
Bile Acids Alter the Autophagy and Mitogenesis in Skeletal Muscle Cells
Tacchi, F., Orozco-Aguilar, J., Valero‐Breton, M., & Cabello‐Verrugio, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-26163-3_10 · Cited by 5
Self-citationMuscle mass, muscle strength and the renin-angiotensin system
Takeshita, H., Yamamoto, K. I., Mogi, M., & Rakugi, H. (2024) · Clinical Science · doi:10.1042/cs20220501 · Cited by 4
Role of the renin-angiotensin-aldosterone system in sepsis and its therapeutic targets
Chen, X., Shao, M. L., Liu, Y., Zhou, J., Cao, F., Liu, Y., Qiu, G., Jiang, T., Huang, M., & Zhang, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115192 · Cited by 5
Gut Microbiota and Aging: Targets and Anti-aging Interventions
Singh, B., Catanzaro, R., Mal, G., Gautam, S., Mohania, He, F., Yadav, H., Bissi, L., & Marotta, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62181-5 · Cited by 4
JNK Signaling Pathway Suppresses LPS-Mediated Apoptosis of HK-2 Cells by Upregulating NGAL
Han, M., Pan, Y., Gao, M., Zhang, J., & Wang, F. (2020) · International Journal of Inflammation · doi:10.1155/2020/3980507 · Cited by 4
“Inhibition of the JNK/MAPK signaling pathway significantly reduces the mortality rate of sepsis [9, 10].”
BackgroundAcuña, M. J., Brandan, E., & Motta‐Santos, D. (2019) · Springer eBooks · doi:10.1007/978-3-030-22696-1_11 · Cited by 5
Self-citationAngiotensin 1–7 increases fiber cross-sectional area and force in juvenile mouse skeletal muscle
Albadrani, H. M., Ammar, T. A. R. A., Rajgara, R. F., Bäder, M., Wiper‐Bergeron, N., & Renaud, J. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00271.2021 · Cited by 3
Therapeutic potential of muscle growth promoters in a stress urinary incontinence model
Yang, J., Balog, B. M., Deng, K., Hanzlicek, B., Rietsch, A. M., Kuang, M., Hatakeyama, S., Lach‐Trifilieff, E., Zhu, H., & Damaser, M. S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00122.2020 · Cited by 5
Albadrani, H. M., Ammar, T. A. R. A., Bäder, M., & Renaud, J. (2021) · The Journal of General Physiology · doi:10.1085/jgp.201912556 · Cited by 3
Vecchiatto, B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2019.tde-01102019-220112 · Cited by 1
Sepsis-associated sarcopenia: Emerging insights into mechanisms and therapeutic approaches
Chang, X., Fan, Z., Wang, J., Guo, Z., Liu, R., Yu, L., Li, J., Yang, F., Luo, X., Pan, C., et al. (2026) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2026.03.005
Metadata
- Authors
- Morales, M. G., Olguín, H., Di Capua, G., Brandan, E., Simon, F., & Cabello-Verrugio, C.
- Affiliations
- Universidad Andrés Bello (CL)
- Pontificia Universidad Católica de Chile (CL)
- Laboratorio de Biología y Fisiopatología Molecular, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas and Facultad de Medicina, Universidad Andres Bello, Santiago, Chile
- Laboratorio de Fisiopatología Integrativa, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas and Facultad de Medicina, Universidad Andres Bello, Santiago, Chile and Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2015-06-22
- Volume
- 129
- Issue
- 6
- Pages
- 461-476
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W326443903
- Cited by
- 62
- References
- 97
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 6 · 2017: 8 · 2016: 7
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- angiotensin-(1-7), Mas receptor, skeletal muscle atrophy, endotoxin, lipopolysaccharide, sepsis, p38 MAPK, atrogin-1, MuRF1, ubiquitin-proteasome system, myosin heavy chain degradation, muscle atrophy, A779
- MeSH terms
- Analysis of Variance, Angiotensin I, Animals, Cells, Cultured, Lipopolysaccharides, Male, Mice, Inbred C57BL, Muscular Atrophy, Myofibrils, Peptide Fragments, Random Allocation, Vasodilator Agents, Muscle, Skeletal, Systemic Inflammatory Response Syndrome, Ubiquitin-Protein Ligases, p38 Mitogen-Activated Protein Kinases, Mice, Muscle Strength, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.